Jiutian Chemical Group Limited

Jiutian Chemical Group Limited

SSGX:C8R
0.02
SGD
+0.00
(+7.14%)
0.03EPS
2.58P/E
167.03MMarket Cap
Mar 03Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.54
0.52
0.37
0.39
0.62
0.72
0.58
0.62
1.09
1.22
0.3
0.03
0.06
0.82
Basic EPS, GAAP
0.01
0.01
- -
- -
0.04
0.01
-0.14
0.09
0.16
0.25
-0.17
-0.07
-0.12
0.16
Free Cash Flow per Basic Share
0.03
0.11
-0.04
-0.02
0.04
0.01
0.03
0.07
0.32
0.21
-0.26
-0.09
-0.07
0.14
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
0.02
0.04
0.06
- -
- -
- -
Book Value per Share
0.24
0.26
0.25
0.25
0.29
0.3
0.17
0.26
0.41
0.61
0.39
0.31
0.19
0.33
Tangible Book Value per Share
0.24
0.25
0.25
0.25
0.29
0.3
0.16
0.26
0.41
0.61
0.38
0.31
0.19
0.33
Basic Weighted Avg Shares
1,795
1,818
1,818
1,818
1,818
1,818
1,818
1,849
1,988
1,988
1,988
1,988
1,988
1,911
Sales/Revenue/Turnover
971
937
678
709
1,124
1,308
1,054
1,146
2,173
2,435
599
51
110
1,558
Operating Margin (%)
1.62
2.32
-3.29
0.3
9.05
6.56
2.71
21.01
28.38
26.52
-51.66
-223.82
-123.04
26.95
Depreciation Expense
28
31
29
30
31
29
28
26
29
22
23
25
37
29
Net Income, GAAP
21
27
-9
1
71
22
-248
174
325
490
-345
-148
-240
299
Effective Tax Rate (%)
- -
3.03
- -
- -
22.5
40.5
- -
28.59
33.12
27.03
- -
- -
- -
28.14
Profit Margin (%)
2.19
2.88
-1.29
0.08
6.3
1.69
-23.56
15.15
14.95
20.14
-57.58
-292.47
-218.42
19.17
Working Capital
-212
-151
-116
-145
-113
-21
10
251
578
992
466
299
135
392
LT Debt
- -
- -
50
50
- -
- -
- -
- -
50
50
66
101
50
- -
Total Equity
439
493
485
485
555
580
301
523
814
1,221
766
618
378
650
Return on Invested Capital (%)
3.92
4.06
- -
- -
11.43
6.25
- -
22.2
32.26
35.6
- -
- -
- -
35.13
Return on Capital (%)
5.28
5.74
- -
- -
11.17
3.23
- -
22.13
34.33
41.06
- -
- -
- -
36.6
Return on Common Equity (%)
5.28
5.97
-1.89
0.13
14.36
4.09
-58.25
42.01
48.46
48.12
-34.67
-21.38
-48.11
60.36

Capital Structure

CNY

•

in mil. unless spec.
Dec'20
Mar'21
Jun'21
ST Debt
344
338
248
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,988
1,988
1,988
Market Capitalization
805
805
802

Working Capital

CNY

•

in mil. unless spec.
Dec'20
Mar'21
Jun'21
Total Current Assets
1,158
1,086
1,275
Cash, Cash Equivalents & STI
260
368
244
Accounts Receivable, Net
53
679
806
Inventories
39
39
36
Total Current Liabilities
907
739
883
Payables & Accruals
- -
- -
- -
ST Debt
344
338
248
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.48%
2.06%
-38.78%
Free Cash Flow
5.88%
16.52%
-13.7%
Net Income, GAAP
1,038.69%
-5.46%
62.02%
Sales/Revenue/Turnover
12.05%
10.32%
116.96%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
51
2025
- -
- -
110
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.07
2025
- -
- -
-0.12
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Hong Guang Wei
Full Time Employees
200
Sector
Process industries
Industry
Chemicals: specialty
Address
350 Orchard Road Singapore CE Singapore 238868
IPO Date
May 10, 2006
Business
Jiutian Chemical Group Limited, incorporated in Singapore in 2004 and listed on the SGX Catalist (C8R), is an investment holding company that manufactures and sells fine chemical products primarily in the People's Republic of China, with operations based predominantly in Henan province and sales extending to surrounding regions including Hebei, Shaanxi, Shanxi, Hubei, Shandong, Jiangsu, Anhui, and the Yangtze Delta area of Jiangsu and Zhejiang. The Group produces dimethylformamide (DMF) as its main product with an annual capacity of 150,000 tons through its wholly-owned subsidiary Anyang Jiutian Fine Chemical Co., Ltd.; methylamine as a secondary product and key feedstock for DMF with capacity supporting up to 250,000 tons; and, through its 49%-owned associate Anyang Jiulong Chemical Co., Ltd. (jointly held with Henan Energy and Chemical Industry Group Co., Ltd.), dimethylacetamide (DMAC), industrial steam, and electricity. It also engages in the processing and sale of consumable carbon dioxide and oxygen-18 and deuterium-depleted water, serving industries such as polyurethane production, pharmaceuticals, agrochemicals, electronics, acrylic fibres, petrochemicals, synthetic resins, leather-making, and food preservation; the Group's headquarters is located at 350 Orchard Road, #21-03 Shaw House, Singapore. Recent developments include the pursuit of business diversification through a proposed Synthetic Ammonia Project and Urea Production Facility lease, with a second extension of the long-stop date announced in March 2025 and ongoing efforts to secure financing, approvals, and construction preparatory work by Anyang Jiutian; multiple board reconstitutions and appointments of new non-executive independent directors including Messrs. Wang Zilong, Wang Hongli, Wong Gang, and Lim Kian Thong in April 2024 alongside retirements of prior directors; a strategic restructuring announcement involving controlling shareholders in September 2025; changes in company secretaries including a resignation in June 2024 and a new appointment in March 2025; and the commencement of members' voluntary winding-up processes for certain associated and dormant subsidiaries in 2024.